BCR and neoplasm: Antigen-specific TCR and BCR repertoires are critical for the recognition of pathogens and malignant cells and may reflect a robust anti-tumor response comprising a large number of antigen specific adaptive immune cells that have undergone clonal expansion and effector differentiation23.